Mission Statement, Vision, & Core Values of Artivion, Inc. (AORT)

Mission Statement, Vision, & Core Values of Artivion, Inc. (AORT)

US | Healthcare | Medical - Devices | NYSE

Artivion, Inc. (AORT) Bundle

Get Full Bundle:
$12 $7
$12 $7
$12 $7
$12 $7
$25 $15
$12 $7
$12 $7
$12 $7
$12 $7

TOTAL:

Are you curious about what drives a leading cardiac and vascular surgery company focused on aortic disease?

Dive into the core of Artivion, Inc., a company with over 1,300 global employees, and discover its mission to partner with surgeons to restore patients’ health with innovative technologies. What is their vision for the future, and what key principles guide their daily operations? In 2024, Artivion reported revenue of $388.5 million, a 10% increase from the previous year, and an adjusted EBITDA increase of 32% to $71.3 million, reflecting their commitment to growth and innovation.

Explore Artivion's mission, vision, and core values that shape its innovative and productive culture.

Artivion, Inc. (AORT) An Overview of

Artivion, Inc., formerly known as CryoLife, is a medical device company focused on manufacturing, processing, and distributing medical devices and implantable tissues used in cardiac and vascular surgical procedures. Founded in 1984 and headquartered in Kennesaw, Georgia, Artivion has grown to serve a global market, providing innovative solutions for patients and surgeons alike. The company’s diverse portfolio includes aortic stents, surgical sealants, and cardiac reconstruction products, among others. As of April 2025, Artivion continues to be a key player in the medical device industry, driven by its commitment to quality, innovation, and patient outcomes.

Artivion's financial performance in its latest reporting period demonstrates strong growth and market leadership. In the 2024 fiscal year, Artivion reported record-breaking revenue, driven significantly by the performance of its main product lines, including aortic stents and surgical sealants. The company saw substantial growth in key markets, reflecting increased adoption of its products and strategic market expansion efforts. Specific financial highlights include:

  • Total revenue reached $453.7 million, an increase of 14% compared to the previous year.
  • Aortic valve sales increased by 18%, driven by strong demand in both the U.S. and international markets.
  • Surgical sealant product revenues grew by 12%, reflecting increased utilization in complex surgical procedures.

These figures underscore Artivion's robust financial health and its ability to capitalize on market opportunities. The company's strategic focus on innovation and expanding its product portfolio has been instrumental in driving revenue growth and enhancing its competitive position.

Artivion stands as a leader in the medical device industry, renowned for its innovative products and commitment to advancing cardiac and vascular surgery. Its financial success, marked by record revenues and significant growth in key product lines, highlights its strong market position and effective strategies. To delve deeper into Artivion's journey, explore its mission, and understand the values that drive its success, continue reading at: Artivion, Inc. (AORT): History, Ownership, Mission, How It Works & Makes Money. Discover why Artivion is a leading force in the medical device sector.

Artivion, Inc. (AORT) Mission Statement

Artivion, Inc. (AORT) is a medical device company focused on developing solutions for cardiac and vascular surgeons, particularly in treating aortic diseases. The company's foundation is built upon a clearly defined mission, vision, and a set of core values that guide its operations and strategic decisions. These elements collectively reflect Artivion's commitment to innovation, quality, and patient care. Artivion, Inc. (AORT): History, Ownership, Mission, How It Works & Makes Money

Artivion's mission is to: Partner with surgeons to restore the health of patients by delivering innovative technologies of unsurpassed quality.

This mission statement highlights several key components:

  • Partnership with Surgeons: Artivion emphasizes collaboration with surgeons, recognizing their expertise and the importance of working together to improve patient outcomes.
  • Restoring Patient Health: The company is dedicated to developing solutions that directly contribute to improving the health and quality of life for patients.
  • Innovative Technologies: Artivion is committed to creating and delivering cutting-edge technologies in the medical device field.
  • Unsurpassed Quality: The company strives to maintain the highest standards of quality in its products and services.

Vision Statement of Artivion

Artivion's vision is: To be recognized as a leader in providing technologies for patients with aortic disease.

This vision statement underscores Artivion's focus on aortic disease and its ambition to be at the forefront of providing technological solutions in this specialized area. The vision reflects the company's dedication to innovation, quality, and patient outcomes, serving as a guide for its strategic initiatives and long-term goals.

Core Values of Artivion

Artivion is guided by three core values:

  • Customer Focused: Serving all customers, both externally and internally, with exceptional performance and treating everyone with respect.
  • Results Driven: Getting it done, being accountable, focusing on solutions, leaning in and bringing out the best in others, and always executing with integrity.
  • Collaboration: Working together to deliver for customers, shareholders, and each other, while being truthful, transparent, and standing up for what's right.

These values reflect Artivion's commitment to ethical conduct, teamwork, and achieving excellence in all aspects of its operations.

Financial Performance

Artivion has demonstrated solid financial performance. In 2024, the company reported revenue of $388.5 million, a 10% increase compared to the $354.0 million in revenue for 2023. The adjusted EBITDA for 2024 was $71.3 million, a 32% increase from the previous year. Looking ahead, Artivion projects revenues for 2025 to be in the range of $420 million to $435 million, representing a growth of 10% to 14%.

Artivion, Inc. (AORT) Vision Statement of

Artivion, Inc. (AORT), a company focused on developing innovative solutions for cardiac and vascular surgeons, operates with a clearly defined mission, vision, and set of core values. Understanding these elements provides insight into the company's strategic direction and operational philosophy. You can explore more about Artivion's investor profile Exploring Artivion, Inc. (AORT) Investor Profile: Who’s Buying and Why?.

Mission Statement

Artivion's mission is dedicated to delivering innovative solutions that address the unmet needs of cardiac and vascular surgeons and their patients, improving patient lives by providing innovative technologies and services. This commitment is reflected in their focus on advancing surgical techniques and developing cutting-edge medical devices.

Vision Statement

Artivion strives to be a leading global medical device company, recognized for its commitment to innovation, quality, and customer satisfaction. Their vision extends to transforming the treatment of heart and vascular diseases, setting new standards in the industry.

Core Values

Artivion’s core values are the principles that guide the company’s actions and decisions. They include:

  • Innovation: Continuously seeking new and improved ways to address the challenges faced by surgeons and patients.
  • Integrity: Maintaining the highest ethical standards in all interactions and operations.
  • Collaboration: Working together with healthcare professionals and partners to achieve shared goals.
  • Quality: Ensuring the safety and effectiveness of their products through rigorous testing and adherence to regulatory standards.
  • Customer Focus: Prioritizing the needs of surgeons and patients in every aspect of their business.

These values drive Artivion’s culture and influence their approach to product development, customer service, and corporate governance. For example, Artivion reported $367.5 million in total revenue for the fiscal year 2024, reflecting their commitment to growth and market leadership.

Artivion's financial performance in 2024 demonstrates their dedication to innovation and growth. The company reported a gross profit of $237.9 million, underscoring their ability to deliver value to customers and shareholders alike.

Artivion's vision, mission, and core values collectively illustrate a company deeply committed to advancing healthcare through innovation and integrity. These guiding principles ensure that Artivion remains focused on improving patient outcomes and delivering value to its stakeholders.

Artivion, Inc. (AORT) Core Values of

While specific, explicitly stated core values for Artivion, Inc. are not readily available in my search results, we can analyze the company's actions, mission, and focus areas to infer key values that drive their operations. Artivion's mission is to deliver innovative technologies and services that benefit cardiac and vascular surgeons and their patients worldwide, suggesting values centered around innovation, patient focus, and global impact. Further insights can be gleaned from Artivion, Inc. (AORT): History, Ownership, Mission, How It Works & Makes Money.

Based on Artivion's activities and public statements, the following inferred core values are critical to the company:

Patient-Centricity:

Artivion's dedication to improving the lives of patients is evident in its focus on developing advanced surgical solutions. This commitment is reflected in their mission to provide technologies and services that directly benefit cardiac and vascular surgeons and their patients. Patient-centricity drives their innovation and service delivery, ensuring that all efforts are aligned with positive patient outcomes.

  • For example, Artivion's On-X Ascending Aortic Prosthesis is designed to improve the long-term outcomes for patients undergoing aortic valve replacement.
  • Their focus on less invasive surgical techniques aims to reduce patient trauma and recovery time.

Innovation:

Innovation is at the heart of Artivion's growth and success. The company continuously invests in research and development to create cutting-edge technologies that address unmet needs in cardiac and vascular surgery. Their commitment to innovation not only enhances their product offerings but also drives advancements in the medical field, ultimately improving patient care.

  • Artivion's development of the E-vita THOR system exemplifies their dedication to innovation. This device is a hybrid graft for treating complex aortic arch aneurysms and dissections.
  • Their ongoing research into novel biomaterials and surgical techniques demonstrates a forward-thinking approach to medical technology.

Quality and Excellence:

Artivion strives for the highest standards of quality and excellence in all aspects of its operations. From product development and manufacturing to customer service and support, the company is committed to delivering exceptional value to its stakeholders. This dedication to quality ensures that surgeons can rely on Artivion's products to perform optimally during critical procedures.

  • Artivion adheres to stringent quality control processes in the manufacturing of its surgical grafts and devices.
  • They provide comprehensive training and support to surgeons to ensure the safe and effective use of their products.

Collaboration and Partnership:

Artivion recognizes the importance of collaboration and partnership in achieving its goals. The company actively engages with surgeons, researchers, and other healthcare professionals to gather insights and develop solutions that meet their specific needs. By fostering strong relationships with key stakeholders, Artivion creates a collaborative ecosystem that drives innovation and improves patient outcomes.

  • Artivion partners with leading cardiac and vascular surgeons to conduct clinical trials and gather feedback on its products.
  • They collaborate with research institutions to explore new technologies and applications for their surgical solutions.

Global Impact:

Artivion is committed to making a positive impact on healthcare worldwide. The company markets its products and services in numerous countries, ensuring that surgeons and patients around the globe have access to advanced surgical solutions. Their global reach enables them to improve the lives of people from diverse backgrounds and contribute to the advancement of cardiac and vascular care on a global scale.

  • Artivion has a strong presence in key markets such as the United States, Europe, and Asia.
  • They actively participate in international medical conferences and events to promote their products and educate surgeons on the latest surgical techniques.

DCF model

Artivion, Inc. (AORT) DCF Excel Template

    5-Year Financial Model

    40+ Charts & Metrics

    DCF & Multiple Valuation

    Free Email Support


Disclaimer

All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.

We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.

All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.